TY - GEN
T1 - Colorimetric On-Chip Detection of Human Papillomavirus for Point-Of-Care Settings
AU - Arockiam, Siril
AU - Nguyen, Vi T.
AU - Anderson, Clifford
AU - Knappenberger, Mark
AU - Anderson, Karen S.
AU - Christen, Jennifer Blain
N1 - Publisher Copyright:
© 2024 IEEE.
PY - 2024
Y1 - 2024
N2 - Point-of-care diagnostics have evolved over the past decade to be a feasible alternative to traditional qPCR testing. Isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) detection have become leading POC diagnostic tools and can be used for cancer-causing persistent viral infections such as high-risk human papillomavirus (HPV). Here, we have developed a colorimetric LAMP assay targeting HPV 16 and 18 L 1 regions for ease of use and instrument-free detection. The diagnostic system comprises of a transparent, 3D-printed microfluidic chip with four reaction wells for simultaneous testing and controls. Validation with spiked synthetic templates demonstrated the LAMP assay's sensitivity, detecting as few as 10-100 copies of HPV DNA per reaction. The limit of detection (LOD) was confirmed through serial dilutions of HPV 16 DNA from 1 to 107 copies. Integration with a syringe and luer lock inlet port facilitated sample treatment, and the assay was tested for both colorimetric and fluorescence detection. Future developments will focus on field testing and clinical validation, inclusion of additional HPV types, and further optimization for routine cervical cancer screening. This POC system offers a promising, rapid, and accessible method for early HPV detection, particularly in resource-limited settings. Clinical relevance-We present an approach to screening for HPV-driven cervical cancer for low resource settings. The colorimetric readout along with the isothermal reaction make the approach reduce the need for expensive, high-precision instrumentation.
AB - Point-of-care diagnostics have evolved over the past decade to be a feasible alternative to traditional qPCR testing. Isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) detection have become leading POC diagnostic tools and can be used for cancer-causing persistent viral infections such as high-risk human papillomavirus (HPV). Here, we have developed a colorimetric LAMP assay targeting HPV 16 and 18 L 1 regions for ease of use and instrument-free detection. The diagnostic system comprises of a transparent, 3D-printed microfluidic chip with four reaction wells for simultaneous testing and controls. Validation with spiked synthetic templates demonstrated the LAMP assay's sensitivity, detecting as few as 10-100 copies of HPV DNA per reaction. The limit of detection (LOD) was confirmed through serial dilutions of HPV 16 DNA from 1 to 107 copies. Integration with a syringe and luer lock inlet port facilitated sample treatment, and the assay was tested for both colorimetric and fluorescence detection. Future developments will focus on field testing and clinical validation, inclusion of additional HPV types, and further optimization for routine cervical cancer screening. This POC system offers a promising, rapid, and accessible method for early HPV detection, particularly in resource-limited settings. Clinical relevance-We present an approach to screening for HPV-driven cervical cancer for low resource settings. The colorimetric readout along with the isothermal reaction make the approach reduce the need for expensive, high-precision instrumentation.
UR - https://www.scopus.com/pages/publications/105000217470
UR - https://www.scopus.com/pages/publications/105000217470#tab=citedBy
U2 - 10.1109/HI-POCT64255.2024.10876207
DO - 10.1109/HI-POCT64255.2024.10876207
M3 - Conference contribution
AN - SCOPUS:105000217470
T3 - 2024 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2024
SP - 45
EP - 48
BT - 2024 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2024
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 2024 IEEE Healthcare Innovations and Point of Care Technologies, HI-POCT 2024
Y2 - 19 September 2024 through 20 September 2024
ER -